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ABSTRACT Autocrine ligands have been demonstrated to regulate cell proliferation, cell adhesion, and cell migration in a number of
different systems and are believed to be one of the underlying causes of malignant cell transformation. Binding of these ligands to
their cellular receptors can be compromised by diffusive transport of ligand away from the secreting cell. Exogenous addition of
antibodies or solution receptors capable of competing with cellular receptors for these autocrine ligands has been proposed as a
means of inhibiting autocrine-stimulated cell behavioral responses. Such "decoys" complicate cellular binding by offering
alternative binding targets, which may also be capable of aiding or abating transport of the ligand away from the cell surface.
We present a mathematical model incorporating autocrine ligand production and the presence of competing cellular and
solution receptors. We elucidate effects of key system parameters including ligand diffusion rate, binding rate constants, cell
density, and secretion rate on the ability of solution receptors to inhibit cellular receptor binding. Both plated and suspension cell
systems are considered. An approximate analytical expression relating the key parameters to the critical concentration of solution
"decoys" required for inhibition is derived and compared to the numerical calculations. We find that in order to achieve essentially
complete inhibition of surface receptor binding, the concentration of decoys may need to be as much as four to eight orders of
magnitude greater than the equilibrium disociation constant for ligand binding to surface receptors.
INTRODUCTION
Binding of a polypeptide ligand to its corresponding cell
membrane receptor can initiate a sequence of events
resulting in a cellular response such as growth, adhesion,
or migration. In vivo, regulatory ligands may originate
from a distant organ, a neighboring tissue, or the actual
target cell itself (Fig. 1). The term autocrine has been
applied to ligands which cells produce capable of bind-
ing to their own receptors (Sporn and Todaro, 1980).
Production of autocrine stimulatory factors may enable
cells to escape exogenous controls and, hence, lead to
apparently unregulated behavior such as that character-
istic of tumor cells (Partridge et al., 1989; Smith et al.,
1987; Yoshida et al., 1990).
One possible means of interrupting an autocrine-
stimulated response is the exogenous addition of soluble
receptors or antibodies targeted to the autocrine ligand.
Acting as "decoys" for the secreted factors, these
soluble receptors may inhibit ligand binding to cell
surface receptors and interfere with the ligand-stimu-
lated behavior. As an example, Cuttitta et al. (1985)
investigated the inhibitory effect of antibodies against
bombesinlike protein (BLP) on the growth of human
small-cell lung cancer (SCLC) xenografts in vivo. SCLC
cells produce and secrete BLP and, further, they express
the appropriate cell surface receptor to BLP. Growth of
SCLC tumors, as measured by tumor volume, was
inhibited by anti-BLP antibodies while control antibod-
ies had no effect. In another example, Imanishi et al.
(1989) investigated the effect of antibodies to transform-
ing growth factor-a (TGF-a) on the growth of human
lung adenocarcinoma cells. Their in vitro study found
that growth inhibition was dependent on antibody con-
centration and that it could be negated by addition of
exogenous TGF-a.
Some debate has centered on whether the ligand-
receptor interaction characterizing an autocrine re-
sponse is an intracellular or cell surface encounter.
Addition of exogenous antibodies or receptors has been
proposed as a means of distinguishing between the two
mechanisms beca'use it should inhibit a cell surface
receptor-ligand interaction but not an intracellular one
(Heldin and Westermark, 1990; Huang et al., 1984; Lang
et al., 1985; Yamada and Serrero, 1988).
A system in which autocrine ligand is secreted and
then must find its appropriate surface receptor will be
dependent not only upon the kinetics of the binding
interaction but also on the extracellular transport prop-
erties of the autocrine factor. When examining inhibi-
tion due to the presence of competing soluble decoys,
these transport considerations may become paramount.
Mathematical modeling can provide a quantitative exam-
ination of these competing processes to aid interpreta-
tion of experimental observations and suggest further
helpful experimental studies.
A previous mathematical model addressing autocrine
systems investigated the effect of inoculum cell density
518 0006-3495/91/02/518/12 $2.00 Biophys. J. o Biophysical Society
Volume 61 February 1992 518-529
0006-3495/91/02/518/12 $2.00
AAA
A AId A
A
Aq
B
A A
Ad
T lymphocytes (Smith, 1990; Duprez et al., 1985). There
is evidence that cell surface receptor-ligand complexes
are the signal generating form of the receptor, at least
for the epidermal growth factor (EGF) system (Wells et
al., 1990), so that inhibition of this complex could lead to
attenuation of the signal. Our analysis reveals that
effective inhibition of surface complex formation can be
attained by a sufficiently high concentration of soluble
receptors but that ligand transport limitations play a key
role in determining the required concentration.
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c A s A
19 A
FIGURE 1 Schematic depiction of ligand secretion cell systems. (A)
Endocrine system: ligand is secreted from the source cell or tissue and
must than travel via the bloodstream and diffuse to the target cell. (B)
Paracrine system: the secreting cell and the target cell are in close
proximity. Ligand diffusion must occur over only a short distant. (C)
Autocrine system: source and target cell are the same cell. Picture
depicts extracellular ligand-receptor interactions although intracellu-
lar interactions have been proposed as a means of autocrine stimula-
tion.
on anchorage-dependent cell growth with the key result
being that the initial growth rate is not simply propor-
tional to surface area coverage by the inoculum cells
(Lauffenburger and Cozens, 1989). This result is consis-
tent with experimental observations by Hu and Wang
(1987) for cells cultured on microcarrier beads. It was
further found that surface geometry could influence cell
growth rate, with higher inoculum densities required for
flat as opposed to spherical surfaces. Goldstein et al.
(1989) considered the effect of competing soluble recep-
tors on cell surface complex dissociation for nonauto-
crine cells. They showed experimentally that soluble
receptors could interfere with diffusion-limited ligand
rebinding indicating that ligand dissociation from mem-
brane receptor complexes could be enhanced by the
presence of these decoys. They also derived a theoretical
expression for the soluble receptor concentration needed
to significantly accelerate dissociation from the cell
membrane.
In this paper, we focus on the effects of soluble decoys
on cell receptor binding of autocrine ligand. Situations
involving cells in suspension and cells on surfaces are
each investigated. Illustrative computations are pro-
vided based on parameter values for the interleukin-2
(IL-2) system, a well-studied autocrine growth factor for
A homogeneous distribution of spherical suspension
cells of radius a form the basis for our mathematical
model (Fig. 2). Ligand is secreted at a constant rate Q
into a secretion layer of thickness 8 surrounding each
cell. Cell receptors are synthesized at a rate V/ and are
homogeneously distributed over the cell surface. The
receptor synthesis rate is considered to be constant and
independent of ligand secretion, thereby setting Vr equal
to R.Ik,, where R. is the total number of surface
receptors found in the absence of ligand secretion and kt
is the constitutive internalization rate for receptors.
Receptor-ligand binding is reversible with on- and
off-rates, kon and koff. The binding of ligand to a cell
receptor may promote a conformational change in the
receptor which allows the complex to enter the cell via
an induced pathway which is not utilized by free recep-
tors. Consequently, internalization of bound and free
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FIGURE 2 Schematic view of the suspension cell model including all
variables and parameters.
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receptors occur at rates ke and k1, respectively, with the
ligand-induced rate considered to be faster than the
constitutive rate (Heldin and Westermark, 1990; Lund
et al., 1990). Free ligand pinocytosis and receptor
recycling are neglected here as second-order effects.
Transient expressions for the change in bound and
unbound surface receptors, C and R respectively, are:
dR
dt =
_ktR-konL*R + koffC + Vr, (1)
dC
t = -keC + k.L*R - koffC. (2)
Note that cellular receptor binding occurs only by ligand
within the secretion layer at concentration L*.
Transport of the ligand to and from the cell primarily
occurs via diffusion. We model this transport as between
adjacent discrete regions, or layers, in order to avoid
cumbersome calculations inherent in a spatially-continu-
ous model (cf. Lauffenburger and Cozens, 1989). With
suspension cells, homogeneous bulk medium surrounds
the secretion layer and it is through this bulk compart-
ment that cell-to-cell communication via ligand trans-
port must occur.
As stated above, the secretion layer surrounding the
cell immediately receives all secreted ligand, and this
ligand is assumed to distribute uniformly within the
secretion layer volume, V*. This ligand binds reversibly
with both cellular and local soluble receptors, R and S *,
and is transported by diffusion with diffusion coefficient,
DL. The soluble receptors' affinity for the ligand may
differ from the cellular surface receptor's affinity and is
characterized by the rate constants ks. and ks, Trans-
port of ligand between the secretion layer and the
surrounding media is characterized by the Smolu-
chowski diffusion-controlled rate constant to a sphere
(Smoluchowski, 1917). The kinetic expression is as
follows:
dL*
V* dt= Q - koL*R + kffC - V*ks,L*S*
+ V*ksX* + A*(L - L*) (3a)
A* = 4ITDL(a + 8). (3b)
In the bulk fluid region, reversible binding with the
appropriate soluble receptors and diffusive transport of
the ligand are included.
dLB
VB dt VBksLBSB + VBkB - A*(LB - L*). (4)
Cell density is reflected in the volume of the bulk fluid
layer, which is evaluated on a per-cell basis. Transport
between neighboring bulk fluid regions is reciprocated.
Our main interest is inhibition of surface complex
formation due to the presence of competing soluble
decoys. Therefore, it is essential that the model incorpo-
rate kinetic expressions for diffusion and reversible
binding of these receptors. Soluble receptors are present
throughout the fluid phases surrounding the cell and
each compartment, secretion layer and bulk medium,
contains a well mixed homogeneous distribution of these
receptors. Diffusion between the compartments occurs,
with a diffusion coefficient Ds. Transport to the cell is
again characterized by the Smoluchowski diffusion-
controlled rate constant to a sphere. Kinetic expressions
for the transient changes in the bound and unbound
soluble receptors within the secretion layer, X* and S*
respectively, are:
dS *
V* dt L*S* + V*ks + As*(SB - S*) (5a)
A* = 4'flDs(a + a) (5b)
dX*
V*dt = V*koL*S*-V*ksffX* + A*(XB- X*). (6)
The kinetic expressions for the bulk medium solution
receptors again include only the reversible binding and
the diffusive flux between compartments and are given
below for the unbound solution receptors:
dSB _
VB dt VBk nLBSB + VBkOffXB - AS(SB - S ) (7)
A mass balance is used in place of a kinetic expression
for the bound soluble receptors in the bulk medium, XB,
with St being the concentration of soluble receptors
added to the medium.
XB =
St(V* + VB) (S* + X*)V* SBVB (8)VB
Computations were performed using parameter val-
ues for the IL2 system. The pertinent system values and
appropriate references are listed below:
IL2:
KD 0.7 * 10-"1M
k0. 3.1 * 107 M-l 5-l
Ro 2,000 receptors/cell
kt 4.6-10-3min-1
ke 4.6 10-2 min-1
(Wang and Smith, 1987);
(Wang and Smith, 1987);
(Wang and Smith, 1987);
(Smith and Cantrell, 1985); and
(Smith, 1988).
Our model segregates the diffusive transport of the
ligand from the binding step. Dissociation rate constants
in both systems were determined from the KD and k1.
values. The association and dissociation rate constant of
the ligand for the soluble receptors, ks. and ksoff are
assumed to be equivalent to the ligand-surface receptor
values. The diffusion coefficients for both the ligand and
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the soluble receptor are estimated from their respective
molecular weights using a semiempirical equation for
large (molecular weight above 1,000) biological solutes
in aqueous solutions as:
DL 10-6cm2/s (Geankopolis, 1983), and
DS 4.0 - 10-'cm2/s (Geankopolis, 1983).
Quantitative measurements of ligand secretion rates
for autocrine cells are complicated by binding which
occurs upon ligand release. Rosenthal et al. (1986)
report a TGF-a secretion rate of 600 molecules/cell-
min for transfected rat fibroblasts while Smith et al.
(1987) report a rate of 0.3 molecules/cells-min for
human pancreatic cancer cells. Leof et al. (1986),
looking at mouse embryo-derived cells, report a secre-
tion rate of 130 molecules/cells-min for platelet-derived
growth factor (PDGF). These experimental estimates
should be viewed as underestimates of secretion rates
due to surface receptor binding. We chose to base our
calculations on a secretion rate of 500 molecules/cell-
min for IL2.
The appropriate volumes required are based on the
cell size and density. Cells and the surrounding secretion
layer are assumed to be spherical and uniformly distrib-
uted.
a 5 10-6m
density 10-5 cells/ml.
Our model is compartment based with length scale 8
characterizing the secretion layer. This parameter is an
artifactual element built into the model and, thus, has no
corresponding experimental measurements. Because
each compartment is assumed to have no spatial gradi-
ents, the value chosen reflects the diffusional transport
capability of the ligand. In accordance with Berg's
assessment that flux lines to an absorbing disk on a
sphere become radial at a distance away from the cell on
the order of the distance between neighboring receptors
(Berg, 1983), our secretion layer thickness reflects the
distance between neighboring homogeneously distrib-
uted receptors. With a cell radius of 5 microns and a
receptor density of 2,000 receptors per cell, an appropri-
ate secretion layer thickness would then be:
8 2 10-7m.
Steady-state analysis of the model initially appeared
desirable but a transient solution covering a time span of
30 h was instead chosen. Transient analysis revealed that
multiple time scales governed the steady state solution
for the multivariable system presented. Receptors and
receptor complexes approach their steady-state values
within hours while ligand concentration require weeks.
Because cellular response has been linked with surface
complex levels, we chose to look over a relatively shorter
time period rather than when the entire system had
reached steady state. Further, experiments designed to
look at the effects of antibodies on cell growth in vitro
are typically completed within 24 h (Huang et al., 1984;
Johnsson et al., 1985; Yoshida et al., 1990). The com-
puter subroutine LSODE, an implicit solver, was used to
solve the system of nonlinear ordinary differential equa-
tions (Hindmarsh, 1980). Equations were scaled and the
following initial conditions were used:
RIRo = 1.0 (all receptors were initially unbound);
CIRo = 0.0 (no complexes);
L*/KD = 0.0 (secretion has not begun yet);
LB/KD = 0.0 (secretion has not begun yet);
S*/St = 1.0 (homogeneously distributed decoy
concentration);
X*/St = 0.0 (secretion has not begun yet);
SB/St = 1.0 (homogeneously distributed decoy
concentration);
XB/St = 0.0 (secretion has not begun yet).
The boundary conditions were chosen to reflect the fact
that secretion was initiated at time zero. Before secre-
tion initiation, all receptors were unbound and the
surrounding media was void of ligand. Soluble receptors
had been added but were unbound, due to the lack of
available ligand in the media.
RESULTS
The primary thrust of our analysis is evaluation of the
ability of solution binding molecules to inhibit cellular
response using surface concentration of receptor com-
plexes as our gauge. As shown in Fig. 3, for a given cell
density, low concentrations of solution decoys have no
effect upon the density of surface complexes present
after 30 h of stimulation. A threshold concentration
must be added to initiate inhibition and this threshold
concentration of soluble receptors is cell-density depen-
dent. A secondary plateau over which increasing concen-
trations of soluble receptors have no further inhibitory
effect exists, in which the level of surface complexes
present is independent of cell density. Total blockage of
cellular complexes is only obtainable at very high concen-
trations of soluble receptors and, this too, is cell density
independent. At a low cell density of 103 cells/ml, the
soluble decoy concentration required to initiate inhibi-
tion is about equivalent to the KD of the surface
receptor-ligand interaction. Higher cell densities re-
quire larger concentrations of decoys to initiate inhibi-
tion, yet, to obtain essentially complete blockage of
binding, given the parameter values for the IL2 system,
would require a decoy concentration of about eight
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FIGURE 3 Effect of cell density, suspension cell model. Shown is the
effect of increasing concentrations of soluble receptors on the level of
surface complexes at various cell densities. Surface complexes are
scaled by the level of surface receptors found in the absence of ligand
stimulation. For visual ease, the concentration of soluble receptors
added is plotted logarithmically. Parameter values for IL2 used for all
calculations with the exception of Fig. A2: kon = 3.1 * 10' M-s kf, =
2.3 *10-4 s-s', ks = 3.1 * 10' M` s', ks = 2.3 * 10-4 5-1,R = 2,000
receptors/cell, k, = 0.0046 min-', ke = 0.046 min-', DL = 10-6 Cm2/S,
Ds = 4.0 * 10-7 cm2/s, Q = 500 molecules/min, a = 5 ,um, 8 = 0.2 p.m.
For all subsequent figures, 105 cells/ml is the standard density used.
times the KD value. This concentration is independent of
cell density, however, increased surface receptor-ligand
affinities do increase the soluble receptor concentrations
required for inhibition (Fig. 7).
The initial plateau of surface complex levels is due to
kinetic limitations. A balance between degradation of
receptors through endocytosis, diffusive transport of
ligand away from the cell, and affinity of the receptor for
the ligand places a natural upper boundary on the level
of surface complexes. This level is dependent on the
local concentration of ligand available to bind to the
receptors. At low cell density, there is a greater concen-
tration gradient driving secreted protein away from the
binding surface so that maximum levels of complexes are
not obtained. At high cell densities, smaller bulk phase
volumes lead to decreased local concentration gradients
but maximum complex levels are still limited by availabil-
ity of unbound surface receptors. This point is empha-
sized by Fig. 4 in which surface complex levels increase
with increasing ligand secretion rates but still are con-
tained by the kinetic limit.
As depicted schematically in Fig. 5, soluble receptors
begin to affect complex formation by binding ligand
within the bulk phase thereby preventing diffusion of
ligand between cells and, further, creating a gradient in
the ligand concentration resulting in an increased driv-
ing force away from the cell. Cell receptor binding still
occurs at this stage due to the influx of ligand from the
C/Ro
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FIGURE 4 Effect of ligand secretion rate, suspension cell model.
Level of scaled surface complexes is shown versus the concentration of
soluble receptors added at various ligand secretion rate's. Parameter
values are listed in Fig. 3.
secreting cell into the secretion layer. It is only when the
number of solution decoys in the ligand secretion layer is
high enough to directly compete with the surface recep-
tors that complete inhibition is obtainable. Because the
secretion layer volume is independent of cell density, the
Complexes
2
Soluble Receptor
Concentration
FIGURE 5 Schematic depicting inhibition process. Soluble receptors
inhibit the level of surface complexes in two regimes. (1) Soluble
receptors within the bulk compartment bind ligand which diffuses into
this compartment thereby preventing further diffusion of this ligand
back to the cell or to neighboring cells; further, this binding increases
the driving force for ligand diffusion out of the secretion compartment.
(2) Soluble receptors within the secretion compartment are now at a
high enough concentration to compete directly with the surface
receptors for the newly secreted ligand.
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level of surface receptor complexes on the transport
limited plateau and subsequent final inhibition require-
ment are cell density independent. Because complex
formation is always dependent on the local secretion
layer concentration of ligand, increased secretion rates
lead to increased local concentrations, and subse-
quently, the level of inhibition obtained in the transport
dependent plateau is decreased (Fig. 4).
Ligand binding can only occur when the ligand is in
close proximity to the receptor. Hence, transport of the
ligand is an important consideration. Transport occurs
via diffusion only and, as shown in Fig. 6A, increasing
this transport rate greatly affects the transport plateau
levels. For lower diffusivities, transport is retarded and
the ligand remains in the vicinity of the cell longer. For
higher diffusivities, the ligand quickly diffuses away from
the cell and complex inhibition on the transport plateau
level is greater. It is only within this transport plateau
region in which ligand diffusion plays a role. To obtain
complete inhibition, the number of solution receptors in
the secretion layer must still be great enough to compete
for the newly secreted ligand.
Because ligand transport played an important role in
the inhibition levels obtainable in the transport plateau
region, the effect of the transport properties of soluble
receptors was considered. As shown in Fig. 6 B, the
diffusive transport of the soluble receptors plays no role
in the inhibition of the cellular complexes after 30 h of
exposure. The analysis assumes that soluble receptors
are uniformly distributed within the surrounding me-
dium and, hence, gradients in their concentration may
be minimized. The ligand is a much smaller molecule
than the soluble receptor and its resulting quicker
diffusion to the bulk medium may further minimize the
effect of soluble receptor transport.
As stated earlier, ligand-receptor affinity is a key
factor in determining the kinetic-limited binding level.
As shown in Fig. 7,A and B, the intrinsic on- and
off-binding rate constants of the receptor also play a role
in determining the extent of inhibition obtainable in the
transport-dependent regime. Varying either the cellular
receptor's association and dissociation rate constants
revealed that increasing affinity decreased the inhibition
levels obtainable within that regime. However, the effect
of the association rate constant is much more pro-
nounced than that of the dissociation rate constant. The
autocrine cell model includes a constant secretion rate
which allows for newly synthesized ligand to be con-
stantly available for receptor binding. An increased
association rate constant increases the rate of binding,
thus decreasing the available ligand for transport away
from the cell. Although a decreased dissociation rate
constant similarly affects the equilibrium affinity of the
complex, it does so not by increasing the levels of initial
A
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FIGURE 6 Effect of transport on inhibition levels, suspension cell
model. (A) Scaled surface complexes are plotted against the concentra-
tion of soluble receptors at various ligand transport rates. Increasing
values of the ligand diffusion ceofficient correspond to increasing
transport rates. (B) Scaled surface complexes versus concentration of
solution receptors at increasing solution receptor transport rates.
Parameter values used for calculations are shown in Fig. 3.
binding but rather by increasing stability of formed
complexes. Apparently, it is the direct kinetic competi-
tion between binding and diffusion which is of para-
mount importance.
In contrast to the solution receptor's transport charac-
teristics, the affinity of the solution ligand-receptor
complex does have an effect on the inhibition levels
obtainable (Fig. 8,A and B). Increasing the decoy's
affinity, by varying either the association or dissociation
rates, has no effect on the kinetic limited binding level
but does influence inhibition in the transport limited
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FIGURE 7 Effect of binding rate constants on inhibitory effect of
solution receptors, suspension model. (A ) Scaled surface complexes
versus the concentration of solution receptors is shown at increasing
values of ligand-receptor association rate constant. Dissociation rate
constant of the surface complex was held constant. (B) Scaled surface
complexes versus solution receptor concentration at increasing ligand-
receptor dissociation rate constants. Association rate constant was
held constant. Parameter values are listed in legend for Fig. 3.
regime. Within this regime, increased affinity does not
affect the transport limited plateau level only the thresh-
old concentration required to reach this plateau. In-
creased affinity for the ligand enables the soluble recep-
tors to compete with the cellular receptors more
effectively. Variations in the association rate constant,
therefore, lead to changes in the soluble receptor
concentration required to directly compete for the newly
secreted ligand and, hence, obtain complete complex
inhibition. While still affecting the threshold concentra-
tion required to initiate inhibition, decreases in the
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FIGURE 8 Effect of binding rate constants on inhibitory effect of
solution receptors, suspension model. (A) Ligand-surface receptor KD
was held constant while the solution receptor association rate constant
was varied. The dissociation rate constant for the ligand-solution
receptor complex was held constant. (B) The dissociation rate con-
stant for the ligand-solution receptor complex was varied while holding
constant the association rate constant. Scaled surface complexes
versus the concentration of solution decoys is shown. Parameter values
are listed in legend for Fig. 3.
dissociation rate constant do not affect the levels of
complex inhibition outside the transport regime. The
effect is a secondary one, not clearly connected to the
direct inhibition of newly synthesized material.
A length scale appropriate for the secretion compart-
ment, 8, was selected based on the separation distance
between neighboring receptors, assuming a uniform
homogeneous arrangement. As stated earlier, this param-
eter is artificial and, as such, its choice is somewhat
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ligand secreting cells. Ligand-receptor binding is depen-
dent not only on the intrinsic rate constants of the
complex but also on the local concentrations of the
primary factors. It is in these local concentrations where
synthesis and diffusion play key roles. This is especially
true for autocrine cells whose response may be amplified
by the proximal location of ligand and receptor synthe-
S1S.
to an increasea We present a mathematical model which investigates
lirectly compet- the effect of a number of parameters on the level of
newly secreted complex inhibition obtainable via the addition of solu-
eptor's binding tion decoys on anchorage-dependent and suspension
h to bind the cells (see Appendix for anchorage-dependent cell model).
Our models demonstrate that inhibition is obtainable
on layer length but the critical concentration of soluble receptors re-
ffusion pathway quired is dependent on the binding affinities of the
ell itself will be competing receptors. Ligand transport plays a key role
noted that even in the process and places a limitation on the inhibition at
-mediate, trans- lower soluble receptor concentrations.
)ncentration of Investigators looking at the effect of antibody addition
iplete inhibition on response of autocrine cells have primarily assayed for
;reater than KD. response changes from control cells (Betsholtz et al.,
1984; Huang et al., 1984; Imanishi et al., 1989). Reduc-
tion in response may be considered evidence that the
presence of the antibody is affecting the cell. However,
to effectively interrupt the autocrine cycle, complete
ptors is thought inhibition of response may be necessary. Huang et al.
e characteristic (1984) examined the effect of several concentrations of
980). Inhibition antiserum on the inhibition of growth of Simian Sar-
ice via solution coma Virus (SSV)-transformed cells. They found that
itibodies, is one 50% inhibition was obtainable at low concentrations of
signal of these antiserum and that a four-fold increase in concentration
had no increased effect. As shown by our results, the
concentration of competing antibody may not have been
- O.004*a high enough to overcome transport limitations. A higher
concentration of antiserum may be able to completely
0.04*a eliminate the response. It would be helpful to predict
-------0.4*a what concentration will be necessary, and a simple
expression relating inhibition to antibody concentration
--- 4.0*a would be desirable.
To obtain such an expression relating the level of
complex inhibition to the required concentration of
soluble competing receptors which must be added,
;-=, several simplifying assumptions are made. Within the
-s -l transport region, essentially all the bulk phase ligand
becomes bound to the competing soluble receptors and
the free ligand concentration within this regime be-
iodel to B. Suspen- comes negligible. Further, to obtain complete inhibition,
ues (see Fig. 3) but the free soluble receptors within the secretion boundary
A 8 are shown as a layer must be able to directly compete with the surface
the standard value receptors. Therefore, it will be assumed that the concen-
tration of bound soluble receptors within the secretion
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FIGURE 9 Examination of the sensitivity of the n
sion cell model using standard IL2 parameter vali
varying 8 over four orders of magnitude. Values c
function of a, the cell radius. 0.04* a corresponds to
for 8 used in previous calculations.
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layer is negligible and the unbound concentration is
equivalent to a constant.
Scaling Eqs. 1, 2, and 3 a, and assuming a quasi-steady
state, the level of unbound surface receptor is:
0 + v
u = 0 + y* (9)
where
u = R IRO
v = CI/Ro
y * =L*IKD
0 = ktkOff.
The quasi-steady state level of surface complexes is:
y*
VO' + 1' (11)
where:
-1 = k, Ik,.
Recalling that all ligand concentrations except for the
secretion boundary layer are considered negligible, the
ligand concentration within this layer is:
a- + pv
y pu + a + P(R)t (2
where:
a= QI(V*koffKD)
p = ROI(V*KD)
D = ks/Ik0,
= S* IKD
a = A* /(kffKD).
Assuming that the transport flux of ligand away from the
cell and the secretion of ligand from the cell itself into
the secretion boundary layer are the dominate terms in
the expression for y *, an expression relating the scaled
concentration of soluble receptors, w,, with the surface
complex level, v, is:
r-va(l + X0)-v
v(1 +0) (13)
Given the previous results and discussion, it is not
surprising that the approximate relationship derived
above should be a function of these particular parame-
ters given the regime for which the equation is appropri-
ate.
Knauer et al. (1984) showed that a linear relationship
exists between the steady-state level of receptor occu-
(10)
pancy and the mitogenic response for the EGF system.
With human fibroblasts, 10% of the maximum cell
response can occur with only 5% of the initial recep-
tors occupied. For complete inhibition of a cellular
response, an extremely low occupancy level would be
desired. A vcritical of 0.1% may, therefore, be quite
appropriate. Given the parameter values for IL2 and
selecting a vc,,tj.j value of .001, the concentration of
soluble receptors which must be added is quite similar to
the concentration necessary using the full system of
differential equations.
St = 8.5 x 10-4 M
(log St = -3.1)
St = 4.5 x 10- M
(log St = -2.4)
approximation,
full system of ODEs.
The approximate solution differs by less than an order of
magnitude from the full system of equations result. Eq.
12 may offer, therefore, a quick estimate of the level of
inhibiting receptors required. It is interesting to note
that the concentration required to obtain this level of
inhibition is about eight orders of magnitude higher than
the IL2 KD value (0.7 x 1011 M). However, both the
approximate expression and the full system of equations
include an autocrine secretion rate, whose value is
crucial to the level of inhibition obtainable. Because this
quantity is currently very difficult to measure experimen-
tally increased attention to its experimental determina-
tion is in order.
A key feature of our model is its emphasis on spatial
heterogeneity for autocrine ligand access to cell surface
receptor binding. In systems where ligand is added
exogenously to the bulk medium, binding to surface
receptors has been treated successfully as a boundary
condition for a ligand diffusion equation (e.g., De Lisi
and Wiegel, 1981; Shoup and Szabo, 1982). For ligand
introduced directly at the cell surface, as in the auto-
crine case, the length scales of the binding and secretion
sites are more difficult to smear into an average bound-
ary condition within a continuously distributed model.
We have therefore chosen to recognize and account for
spatial distribution of ligand by a simple compartmental-
ized model, in which ligand close to the cell surface (the
secretion layer) and far from the surface (the bulk
medium) do indeed possess different kinetic possibilities
for receptor binding. The length scale of binding site
distribution is reflected in the value chosen for the
secretion layer thickness, 8, as suggested by Berg (1983).
We believe that this compartmentalized model gener-
ates predictions allowing increased intuitive understand-
ing, as well as improved quantitative guidelines, for
binding inhibition by solution decoys. Although the
sharpness of the transport-limited inhibition plateau is
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overestimated by the discrete compartmentalization ap-
proach, we suggest that there ought indeed to be often
found such an intermediate level of inhibition. The
experimental results of Huang et al. (1984) may indeed
be evidence of this. Ultimately, however, the most
rigorous analysis of autocrine ligand binding to cell
surface receptors will probably require a noncontinuum
modeling approach, such as application of Brownian
dynamics simulation techniques for the region close to
the cell surface.
levels. Good agreement was obtained between the full
computer model results and the approximation solution,
Eq. 12, indicating that the simple expression may allow
quick estimates to be made before experimentation.
Calculations indicate that soluble receptor concentra-
tions as high as between four and eight orders of
magnitude greater than the receptor-ligand KD value
may be necessary to completely interrupt the autocrine
secretion signal.
SUMMARY
Many cellular responses governed through surface recep-
tor-ligand binding might be inhibited through the addi-
tion of decoy receptors or antiligand particles aimed at
disrupting this initial binding interaction. This interrup-
tion may be especially crucial in controlling autocrine
cells because production of receptors, secretion of the
ligand, and binding between the two molecules occur
within the same cell's sphere of influence and other
means of signal interruption may be more difficult.
A kinetic model was presented incorporating the
reversible binding of the soluble receptors with the
autocrine factor into its framework. Suspension and
anchorage-dependent (see Appendix for comparison
between the two model cell types) cells were treated
separately, but the primary results were independent of
the geometric configuration of the system. At low
concentrations of soluble receptors there was essentially
no inhibition of surface complexes. Once a threshold
concentration had been added, partial inhibition could
be obtained with the level of inhibition being dependent
on such factors as receptor affinity, transport rate of the
ligand, and secretion rate. The cellular density and
affinity of the soluble receptor played roles only in the
threshold concentration required but not in the inhibi-
tion level obtainable. However, this initial inhibition
level is transport limited. Complete inhibition is not
obtainable until all bulk ligand has been bound and the
concentration of soluble receptors within the secretion
layer is high enough to directly compete with the surface
receptors for the secreted ligand. This second threshold
is dependent on the association constants of the compet-
ing receptors. An important observation obtained
through the models is the independence of inhibition on
the transport of the competing receptors. Primarily,
inhibition is dependent on cellular-derived parameters.
Modified soluble receptors prove beneficial in as far as
the ratio of their association constant with that of the
cellular receptor's is high.
A simplified expression was derived relating the
concentration of inhibitory receptors to surface complex
APPENDIX
Many autocrine cell systems involve cell types which are anchorage-
dependent and will not grow in suspension (Imanishi et al., 1989; Van
de Vijver et al., 1991). Cellular arrangement might, therefore, play a
pivotal role in response inhibition. We modified our suspension cell
model to examine the response of these types of anchorage-dependent
systems.
Primarily, the two models differ in their compartmentalization. The
suspension cell model contains a secretion layer and a bulk fluid phase
and it is only through this outer compartment that cell to cell
communication can occur. In the plated cell model, fluid mixing
properties close to the solid surface will be influenced by this physical
boundary leading to a mass transfer layer. Hence, this model contains
a boundary layer connecting the secretion layers of each cell and
separating these secretion layers from the bulk fluid phase. Ligand
diffusive transport through the mass transfer boundary layer is
characterized by a transfer coefficient which incorporates appropriate
length scales bi, the height of the layer, and *, one half the distance
between the centers of neighboring plated cells.
A direct comparison between the inhibition effect of solution
receptors on surface complex levels in both the anchorage-dependent
and -independent models is shown in Fig. Al. In both models,
parameter values were based on the IL system and qualitatively, both
show the same pattern of inhibition. At low cell densities, neither
configuration allows for maximal levels of surface complexes indicat-
ing, perhaps, a suboptimal response. However, plated cells do show a
0.12
105 cells/ml
0.1 ' -- suspension
0.08
- plated
C/Ro
-17 -13 -9 -5 -1
log (St) M
FIGURE Al Comparison of geometrical effects. At both 103 and 105
cells/ml, inhibition of surface complexes due to the presence of
competing solution receptors is shown for both the suspension and
plated cell model. IL-2 parameter values were used in both models to
allow direct comparison of purely geometric effects.
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FIGURE A2 Effect of solution receptor addition on autocrine plated
cells, EGF parameter values. Scaled surface complexes versus the
concentration of inhibitory solution receptors added at various cell
densities. EGF parameter values used in calculations: ko = 3. 106 M -l
s 1',k=ff 1.4*10-2s-, ks = 3*106 M` s-', k,s = 1.4 -10-2s -', Ro = 105
receptors/cell, k, = 0.03 min-', kc = 0.3 min-', DL = 10-6 cm2/s, DS =4 -
10-' cm2/s, Q = 5,000 molecules/min, a = 5 p.m, 8 = 0.3 p,m, b = 25
pm, total plate volume = 10 ml.
higher level of surface complexes than do the suspension cells. The
close proximity of neighboring cells offers a further resistance to
diffusion into the bulk fluid and an attraction towards the cell. This
same geometrical binding advantage conveyed on plated cells is
evident in the presence of soluble receptors throughout the transport
dependent region although both models do exhibit complete complex
inhibition when exposed to sufficiently high soluble receptor concentra-
tions.
High density cultures are situated close enough to each other that
the binding advantage of plated cells over suspension cells is not
evident. However, with the addition of increasing concentrations of
competing receptors, plated cells show a higher resistance to inhibition
than do suspension cells. This is especially evident in the transport
dependent regime. Previous mathematical analysis comparing auto-
crine cell growth on spherical and flat surfaces demonstrated that
geometrical differences can affect growth behavior primarily through
ligand transport differences (Lauffenburger and Cozens, 1989). As
shown in Fig. 5, a transport dependent plateau level of surface
complexes is obtained when a sufficiently high enough concentration
has been added to bind bulk phase ligand and prevent diffusional
communication or back diffusion to the cell itself. However, plated
cells still have a growth advantage due to their reduced rate of transfer
to the bulk phase.
To facilitate comparison of geometrical effects between the two
mathematical models, IL2 parameter values were incorporated into
both. However, IL2 is an autocrine factor for lymphocytes, an
anchorage-independent cell type, so parameter values for EGF, a
growth factor of fibroblasts, would yield more physiologically-
meaningful results. Using parameter values for the EGF system,
comparable calculations to those shown in Fig. 3 for the suspension
cell model were evaluated. Comparison between Figs. Al and A2
reveal that the EGF system yields qualitatively the same pattern of
inhibition seen in the IL2 system. However, the transport dependent
regime in the EGF system shows strikingly reduced levels of surface
complexes when compared with the IL2 system. This is primarily due
to the higher association rate constant of IL2 for the IL2 receptor as
opposed to the EGF/EGF receptor complex. As depicted in Fig. 7A,
the association rate constant greatly influences the level of surface
complexes found within the transport dependent regime. Parameter
values used for the EGF/EGFR system are shown with Fig. A2.
The length scale for the mass transfer boundary layer, B, is an
artificial parameter which cannot be experimentally determined.
However, varying this parameter over five orders of magnitude did not
affect either the surface complex inhibition levels or the soluble
receptor concentration profile (results not shown).
We are grateful to Dr. D. D. Brengel for helpful discussions regarding
computational methods.
This work has been partially supported by grants from the National
Science Foundation Biotechnology Program.
Received for publication 15 April 1991 and in final form 13
August 1991.
REFERENCES
Berg, H. C. 1983. Random Walks in Biology. Princeton University
Press, Princeton, New Jersey. 17-36.
Betsholtz, C., B. Westermark, B. Ek, and C.-H. Heldin. 1984. Coexpres-
sion of a PDGF-like growth factor and PDGF receptors in a human
osteosarcoma cell line: implications for autocrine receptor activa-
tion. Cell. 39:447-457.
Cuttitta, F., D. N. Carney, J. Mulshine, T. W. Moody, J. Fedorko, A.
Fischler, and J. D. Minna. 1985. Bombesin-like peptides can
function as autocrine growth factors in human small-cell lung
cancer. Nature (Lond.). 316:823-826.
DeLisi, C., and F. W. Wiegel. 1981. Effect of nonspecific forces and
finite receptor number on rate constants of ligand-cell bound-
receptor interactions. Proc. Natl. Acad. Sci. USA. 78:5569-5572.
Duprez, V., G. Lenoir, and A. Dautry-Varsat. 1985. Autocrine growth
stimulation of a human T-cell lymphoma line by interleukin 2. Proc.
Natl. Acad. Sci. USA. 82:6932-6936.
Geankoplis, C. J. 1983. Transport Processes and Unit Operations.
Allyn and Bacon, Inc., Boston, Massachusetts. 394-395.
Goldstein, B., R. G. Posner, D. C. Torney, J. Erickson, D. Holowka,
and B. Baird. 1989. Competition between solution and cell surface
receptors for ligand. Biophys. J. 56:955-966.
Heldin, C.-H., and B. Westermark. 1990. Platelet-derived growth
factor: mechanism of action and possible in vivo function. Cell
Regulation. 1:555-566.
Hindmarsh, A. C. 1980. LSODE and LSODI, two new initial value
ordinary differential equation solvers. ACM-Signum Newsletter. 15:
10-11.
Hu, W.-S., and D. I. C. Wang. 1987. Selection of microcarrier diameter
for the cultivation of mammalian cells on microcarriers. Biotechnol.
Bioeng. 30:548-557.
Huang, J. S., S. S. Huang, and T. F. Deuel. 1984. Transforming protein
of simian sarcoma virus stimulates autocrine growth of SSV-
transformed cells through PDGF cell-surface receptors. Cell. 39:79-
87.
Imanishi, K., K. Yamaguchi, M. Kuranami, E. Kyo, T. Hozumi, and K.
Abe. 1989. Inhibition of growth of human lung adenocarcinoma cell
lines by anti-transforming growth factor-a monoclonal antibody. J.
Natl. CancerInst. 81:220-223.
Johnsson, A., C. Betsholtz, C.-H. Heldin, and B. Westermark. 1985.
Antibodies against platelet-derived growth factor inhibit acute
transformation by simian sarcoma virus. Nature (Lond.). 317:438-
440.
528 Biophysical Journal Volume 61 February 1992
Knauer, D. J., H. S. Wiley, and D. D. Cunningham. 1984. Relationship
between epidermal growth factor receptor occupancy and mitogenic
response. J. Bio. Chem. 259:5623-5631.
Lang, R. A., D. Metcalf, N. M. Gough, A. R. Dunn, and T. J. Gonda.
1985. Expression of a hemopoietic growth factor cDNA in a
factor-dependent cell line results in autonomous growth and tumor-
igenicity. Cell. 43:531-542.
Lauffenburger, D. A., and C. Cozens. 1989. Regulation of mammalian
cell growth by autocrine growth factors: analysis of consequences for
inoculum cell density effects. Biotechnol. Bioeng. 33:1365-1378.
Leof, E. B., J. A. Proper, A. S. Goustin, G. D. Shipley, P. E. DiCorleto,
and H. L. Moses. 1986. Induction of c-sis mRNA and activity similar
to platelet-derived growth factor by transforming growth factor ,: a
proposed model for indirect mitogenesis involving autocrine activ-
ity. Proc. Natl. Acad. Sci. USA. 83:2453-2457.
Lund, K. A., L. K. Opresko, C. Starbuck, B. J. Walsh, and H. S. Wiley.
1990. Quantitative analysis of the endocytic system involved in
hormone-induced receptor internalization.J. Biol. Chem. 265:15713-
15723.
Partridge, M., M. R. Green, J. D. Langdon, and M. Feldmann. 1989.
Production of TGF-a and TGF-f by cultured keratinocytes, skin
and oral squamous cell carcinomas-potential autocrine regulation
of normal and malignant epithelial cell proliferation. Br. J. Cancer.
60:542-548.
Rosenthal, A., P. B. Lindquist, T. S. Bringman, D. V. Goeddel, and R.
Derynck. 1986. Expression in rat fibroblasts of a human transform-
ing growth factor-a cDNA results in transformation. Cell 46:301-
309.
Shoup, D., and A. Szabo. 1982. Role of diffusion in ligand binding to
macromolecules and cell-bound receptors. Biophys. J. 40:33-39.
Smith, J. J., R. Derynck, and M. Korc. 1987. Production of transform-
ing growth factor a in human pancreatic cancer cells: evidence for a
superagonist autocrine cycle. Proc. Natl. Acad. Sci. USA. 84:7567-
7570.
Smith, K. A. 1988. Interleukin-2. A 10-year perspective. In Interleukin
2. K. A. Smith, editor. Academic Press, Inc., San Diego, California.
1-35.
Smith, K. A. 1990. Interleukin-2. Sci. Am. 262:50-57.
Smoluchowski, M. V. 1917. Versuch einer mathematischen theorie der
koagulationskinetik kolloider losungen. Z Phys. Chem. 92:129-168.
Sporn, M. B., and G. J. Todaro. 1980. Autocrine secretion and
malignant transformation of cells. N. Engl. J. Med 303:878-80.
Van de Vijver, M. J. 1991. Ligand-induced activation of A431 cell
epidermal growth factor receptors occurs primarily by an autocrine
pathway that acts upon receptors on the surface rather than
intracellularly. J. Biol. Chem. 266:7503-7508.
Wang, H.-M., and K. A. Smith. 1987. The interleukin 2 receptor
functional consequences of its biomolecular structure. J. Exp. Med.
166:1055-1069.
Wells, A., J. B. Welsh, C. S. Lazar, H. S. Wiley, G. N. Gill, and M. G.
Rosenfeld. 1990. Ligand-induced transformation by a non-internal-
izing epidermal growth factor receptor. Science (Wash. DC). 247:962-
964.
Yamada, Y., and G. Serrero. 1988. Autocrine growth induced by the
insulin-related factor in the insulin-independent teratoma cell line
1246-3A. Proc. Natl. Acad. Sci. USA. 85:5936-5940.
Yoshida, K., E. Kyo, T. Tsuda, T. Tsujino, M. Ito, M. Niimoto, and E.
Tahara. 1990. EGF and TGF-a, the ligands of hyperproduced
EGFR in human esophageal carcinoma cells, act as autocrine
growth factors. Int. J. Cancer. 45:131-135.
Forsten and Lauffenburger Autocrine Cells: Effect of Decoys 529
